Serological Screening of Gastric Cancer in Wuxi Region

计划入组 5,000 人 · 首次发布于 2016 年 1 月 26 日

A Phase III Clinical Trial Assessing the Immunogenicity and Safety of Lyophilized Live-Attenuated Varicella Vaccine in Healthy Subjects Aged 13 to 55 Years

计划入组 1,200 人 · 首次发布于 2024 年 9 月 12 日

Vaccination Study of Abatacept (BMS-188667) for Normal Healthy Volunteers

计划入组 80 人 · 首次发布于 2006 年 1 月 20 日

Inactivated Whole-cell Pneumococcal Vaccine(GPN Vaccines)

Macrocyclic CEN Inhibitor(WuXi AppTec)

Bispecific antibodies(Aravive/WuXi Biologics)

WuXi AppTec, Inc.

China

WuXi Biologics Co., Ltd.

China

Wuxi Apptec Sales, LLC

United States

Merck & Co. to Acquire WuXi Biologics' Vaccine Facility in Ireland for $500 Million

MSD Acquires WuXi Biologics' Irish Vaccine Facility for $500M Amid Regulatory Pressures

WuXi Biologics Receives EMA Approval for Ireland Manufacturing Facility, Advancing Global Dual Sourcing Strategy